Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumors

Explore clinical trials studying Advanced Solid Tumors. Study availability and eligibility vary by location and protocol.

609 public trials 183 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumors trial results

Active, Not Recruiting

A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors

NCT05537740

Conditions
Advanced Solid Tumors, Breast Diseases, Breast Neoplasms, +30 more
Locations
  • The University of Chicago Medical Center - Hyde Park - Hematology & Oncology Chicago, Illinois, United States
  • UNC Hospitals - UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • START | San Antonio San Antonio, Texas, United States
  • South Texas Accelerated Research Therapeutics | START Rocky Mountain Region West Valley City, Utah, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer

NCT06239467

Conditions
Advanced Cancer, Advanced Solid Tumors, Breast Cancer, +7 more
Locations
  • California Cancer Associates for Research and Excellence Encinitas, California, United States
  • University of California San Diego UCSD La Jolla, California, United States
  • UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag - Huntington Beach Newport Beach, California, United States
View all 33 locations
View Trial Details
Active, Not Recruiting

A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers

NCT04626635

Conditions
Advanced Solid Tumors
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • University of California Los Angeles (UCLA) Medical Center Los Angeles, California, United States
  • The Regents of the University of California, San Francisco San Francisco, California, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion - Lung Cancer Clinic Aurora, Colorado, United States
View all 54 locations
View Trial Details
Active, Not Recruiting

A Phase 1 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Advanced Solid Tumors

NCT06394414

Conditions
Advanced Solid Tumors
Locations
  • Peking University Cancer Hospital Beijing, Beijing Municipality, China
  • Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijinig, China
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • Fujian Provincial Cancer Hospital Fuzhou, Fujian, China
View all 25 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors

NCT06873789

Conditions
Advanced Solid Tumors, Metastatic Solid Tumors, Solid Tumors
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Valkyrie Clinical Trials Panorama City, California, United States
  • University of Florida Health Shands Hospital Gainesville, Florida, United States
  • Cancer and Hematology Centers of Western Michigan-Start Midwest Grand Rapids, Michigan, United States
View Trial Details
Active, Not Recruiting

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

NCT07038369

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Cancer, +46 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Florida Cancer Specialists & Research Institute - Lake Mary Lake Mary, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

NCT04449874

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +23 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Chao Family Comprehensive Cancer Center UCI Orange, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 64 locations
View Trial Details
Active, Not Recruiting

A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

NCT06131398

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +29 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Alliance for Multispecialty Research - Kansas City Merriam, Kansas, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
View all 25 locations
View Trial Details

Related conditions